Subscribe

Business

Schizophrenia: “The Forgotten Illness”?
Breakthrough Therapy, or Breakthrough Pricing?
Can Substituting Generic Drugs with Brand-Name Agents for Acute Pain Postsurgery Help to Deliver Cost-Effective, Quality Care?
Modeling the Future Economic Impact of Biosimilars’ Entry into the US Market
CAP Is a Burden for All Ages—Prevention Strategies Are Key
Innovation in Patient Engagement and Management Is Critically Needed to Change Current Trends in Type 2 Diabetes
Much More than Biomarkers: Sociodemographic Variables in Personalized Medicine
New Oncology Care Delivery Payment Models to Enhance Care Efficiency
Cost and Effectiveness of Therapies for Advanced Kidney Cancer: The Need for Economic and Clinical Analyses
Page 8 of 14
Results 71 - 80 of 136
Copyright © Engage Healthcare Communications, LLC. All rights reserved.